-
www.cahps.ahrq.gov/opioids/data/analyses.html
November 01, 2022 - prepublication, 24 December 2019. doi: 10.1016/j.addbeh.2019.106268
Price elasticity of demand for buprenorphine
-
www.cpsi.ahrq.gov/opioids/data/analyses.html
November 01, 2022 - prepublication, 24 December 2019. doi: 10.1016/j.addbeh.2019.106268
Price elasticity of demand for buprenorphine
-
www.qualitymeasures.ahrq.gov/opioids/data/analyses.html
November 01, 2022 - prepublication, 24 December 2019. doi: 10.1016/j.addbeh.2019.106268
Price elasticity of demand for buprenorphine
-
www.innovations.ahrq.gov/opioids/data/analyses.html
November 01, 2022 - prepublication, 24 December 2019. doi: 10.1016/j.addbeh.2019.106268
Price elasticity of demand for buprenorphine
-
www.monahrq.ahrq.gov/opioids/data/analyses.html
November 01, 2022 - prepublication, 24 December 2019. doi: 10.1016/j.addbeh.2019.106268
Price elasticity of demand for buprenorphine
-
www.healthcare411.ahrq.gov/opioids/data/analyses.html
November 01, 2022 - prepublication, 24 December 2019. doi: 10.1016/j.addbeh.2019.106268
Price elasticity of demand for buprenorphine
-
www.talkingquality.ahrq.gov/opioids/data/analyses.html
November 01, 2022 - prepublication, 24 December 2019. doi: 10.1016/j.addbeh.2019.106268
Price elasticity of demand for buprenorphine
-
ce.effectivehealthcare.ahrq.gov/opioids/data/analyses.html
November 01, 2022 - prepublication, 24 December 2019. doi: 10.1016/j.addbeh.2019.106268
Price elasticity of demand for buprenorphine
-
psnet.ahrq.gov/issue/racial-inequality-receipt-medications-opioid-use-disorder
July 20, 2016 - opioid use disorder (OUD) include prescribing medications to treat OUD ( naltrexone , naloxone, or buprenorphine … White patients were significantly more likely to receive buprenorphine and less likely to receive high-risk
-
www.ahrq.gov/research/findings/studies/index.html?page=30
January 01, 2024 - Engagement
Cook RR , Foot C , Arah OA Estimating the impact of stimulant use on initiation of buprenorphine … Stimulant use had a larger negative impact on XR-NTX initiation compared to buprenorphine, especially … The researchers concluded that stimulant use is a barrier to buprenorphine or XR-NTX initiation in clinical … Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone
-
www.ahrq.gov/research/findings/studies/index.html?page=187
January 01, 2024 - McClellan C , Fingar KR , Ali MM AHRQ Author: McClellan C Price elasticity of demand for buprenorphine … insurance coverage, the researchers examined the relationship between cost sharing and the number of buprenorphine … Price elasticity of demand for buprenorphine/naloxone prescriptions.
-
www.ahrq.gov/research/findings/studies/index.html?page=225
January 01, 2024 - Elderly, Health Information Technology (HIT), Medication
Hartung DM , Johnston K , Geddes J Buprenorphine … This letter discusses a study which looked into coverage of buprenorphine for opioid use disorder (OUP … Buprenorphine coverage in the Medicare Part D program for 2007 to 2018.
-
www.ahrq.gov/news/newsletters/e-newsletter/791.html
November 01, 2021 - Medical Expenditure Panel Survey to estimate the financial costs faced by the population receiving buprenorphine
-
psnet.ahrq.gov/sites/default/files/2023-01/spotlight_overdose_of_gabapentin_and_oxycodone_in_a_patient_with_end-stage_renal_disease.pdf
January 01, 2023 - opioid naïve patients)
Dialyzable
Recommended Hydromorphone 1-2 mg oral every 4 h as needed Yes
Buprenorphine … monitoring in patients with
CKD. 12
18
Review of Analgesics in Renal Dysfunction (Opioids) (4)
• Buprenorphine … • Therefore, buprenorphine and hydromorphone are considered first-line in
the management of pain in
-
psnet.ahrq.gov/issue/systematic-biases-group-decision-making-implications-patient-safety
February 22, 2023 - mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine … mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine
-
www.ahrq.gov/news/newsletters/e-newsletter/886.html
October 01, 2023 - barriers common to conventional OUD treatment and prioritizes “medication first” through prescribing buprenorphine
-
www.ahrq.gov/research/findings/studies/index.html?page=79
January 01, 2024 - balanced by reductions in mortality while receiving medication-assisted treatment (MAT) with methadone or buprenorphine … Methadone treatment for 4 months or longer or buprenorphine for 2 months or longer resulted in 54 and … necessary to achieve net mortality benefits of 2 months or longer for methadone and 1 month or longer for buprenorphine
-
www.ahrq.gov/research/findings/studies/index.html?page=158
January 01, 2024 - Quality Improvement, Quality of Care
Samples H , Williams AR , Crystal S Impact of long-term buprenorphine … Impact of long-term buprenorphine treatment on adverse health care outcomes In Medicaid. … Impact of long-term buprenorphine treatment on adverse health care outcomes In Medicaid..
-
psnet.ahrq.gov/issue/improvement-cymru
December 08, 2010 - mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
September 30, 2015 - cardiac or pulmonary issues; homeless or on parole; current medication contraindicated with methadone or buprenorphine … ; history of methadone/buprenorphine maintenance; pregnant; liver disease (note: from Neumann 2013) A … Sublingual buprenorphine / naloxone (8/2 to 16/4 mg daily) (10 assigned, 4 f/u)
B. … 50 morphine milligram equivalents Exclusion: cancer, hospice, palliative care, and those prescribed buprenorphine